Richard S. Levy, Director at Protara Therapeutics, Inc. (TARA), bought 20,000 shares at $3.19 ($64K) on 2025-05-14, disclosed to the SEC on 2025-05-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MDGL | SELL | 2024-11-08 | $1.8M | — | Filing → |
| MDGL | SELL | 2024-11-05 | $2.7M | — | Filing → |
| MDGL | SELL | 2024-04-03 | $4.1M | — | Filing → |